Showing results (1-10 of 389) with videos related to

Sort By:
Pageof 39
Journal of the Advanced Practitioner in Oncology|June 4, 2021
FDA and Its Role in Drug DevelopmentRichard Pazdur
Journal of the National Cancer Institute|March 15, 2024
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysisJaleh Fallah, Haley Gittleman, Chana Weinstock, et al.
The Oncologist|June 17, 2008
Endpoints for assessing drug activity in clinical trialsRichard Pazdur
Critical Reviews in Oncology/Hematology|May 15, 2002
Oncology drug development: United States Food and Drug Administration perspectiveSteven Hirschfeld, Richard Pazdur
Journal of the National Comprehensive Cancer Network : JNCCN|September 22, 2009
Oncology drug review processAnn T Farrell, Richard Pazdur
Clinical Imaging|November 17, 2012
Rotator cuff tears: association with acromion angulation on MRIJoseph C McGinley, Sundeep Agrawal, Sandip Biswal
Seminars in Oncology|March 13, 2016
Looking to the future in an unprecedented time for cancer drug developmentPaul G Kluetz, Richard Pazdur
Oncology (Williston Park, N.Y.)|June 25, 2004
Progress in the development of novel treatments for colorectal cancerPaulo M Hoff, Richard Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2024
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled AnalysisJaleh Fallah, Jianjin Xu, Chana Weinstock, et al.
Pageof 39